Lower ambulatory blood pressure in chronic fatigue syndrome

Psychosomatic Medicine

Volumn 71, Issue 3, 2009, Pages 361-365

  Newton, Julia L ^a,b   Sheth, Amish ^a   Shin, Jane ^a   Pairman, Jessie ^a   Wilton, Katharine ^a   Burt, Jennifer A ^a   Jones, David E J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Autonomic function; Blood pressure; Chronic fatigue syndrome; Diurnal variation; Fatigue; Primary biliary cirrhosis

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR PARAMETERS; CHRONIC FATIGUE SYNDROME; CIRCADIAN RHYTHM; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; FATIGUE IMPACT SCALE; FEMALE; FUKUDA DIAGNOSTIC CRITERIA; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; OBSERVATIONAL STUDY; PHENOTYPE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE; BILIARY CIRRHOSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HEART RATE; HYPOTENSION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

MIDODRINE; VASOCONSTRICTOR AGENT;

BLOOD PRESSURE MONITORING, AMBULATORY; FATIGUE SYNDROME, CHRONIC; FEMALE; HEART RATE; HUMANS; HYPOTENSION; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; MIDODRINE; VASOCONSTRICTOR AGENTS;

EID: 68549122686     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0b013e31819ccd2a     Document Type: Article

References (47)

1. Yamamoto Y, LaManca JJ, Natelson BH. A measure of heart rate variability is sensitive to orthostatic challenge in women with chronic fatigue syndrome. Exp Biol Med 2003;228:167-74.
2. Stewart JM. Autonomic nervous system dysfunction in adolescents with postural tachycardia syndrome and chronic fatigue syndrome is characterised by attenuated vagal baroreflex and potentiated sympathetic vasomotion. Paed Res 2000;48:218-26.
3. Naschitz JE, Yeshurun D, Rosner I. Dysautonomia in chronic fatigue syndrome: facts, hypotheses, implications. Med Hypotheses 2004;62: 203-6.
4. Winkler AS, Blair D, Marsden JT, Peters TJ, Wessely S, Cleare AJ. Autonomic function and serum erythropoietin levels in chronic fatigue syndrome. J Psychosom Res 2004;56:179-83.
5. Newton JL, Okonkwo O, Sutcliffe K, Seth A, Shin J, Jones DEJ. Symptoms of autonomic dysfunction in chronic fatigue syndrome. QJM 2007;100:519-26.
6. Naschitz JE, Sabo E, Naschitz S, Rosner I, Rozenbaum M, Fields M, Isseroff H, Priselac RM, Gaitini L, Eldar S, Zukerman E, Yeshurun D. Haemodynamics instability score in chronic fatigue syndrome and in non-chronic fatigue syndrome. Sem Arth Rheum 2002;32:141-8.
7. Streeten DH, Thomas D, Bell DS. The roles of orthostatic hypotension, orthostatic tachycardia and subnormal erythrocyte volume in the pathogenesis of the chronic fatigue syndrome. Am J Med Sci 2000;320:1-8.
8. Jones JF, Nicholson A, Nisenbaum R, Papanicolaou DA, Solomon L, Boneva R, Heim C, Reeves WC. Orthostatic instability in a population-based study of chronic fatigue syndrome. Am J Med 2005;118:1415.
9. Van de Luit L, van der Meulen J, Cleophas TJ, Zwinderman AH. Amplified amplitudes of circadian rhythms and nighttime hypotension in patients with chronic fatigue syndrome: improvement by inopamil but not by melatonin. Angiology 1998;49:903-8.
10. Li Y, Boggia J, Thijs L, Hansen TW, Kikuya M, Björklund- Bodegård K, Richart T, Ohkubo T, Kuznetsova T, Torp-Pedersen C, Lind L, Ibsen H, Imai Y, Wang J, Sandoya E, O'brien E, Staessen JA, International Database on Ambulatory Blood Pressure Monitoring in relation to Cardiovascular Outcomes Investigators. Is blood pressure during the night more predictive of cardiovascular outcome than during the day? Blood Press Monit 2008;13:145-7.
11. Boggia J, Li Y, Hansen TW, Kikuya M, Björklund-Bodegård K, Richart T, Ohkubo T, Kuznetsova T, Torp-Pedersen C, Lind L, Ibsen H, Imai Y, Wang J, Sandova E, O'Brien E, Staessen JA, International Database on Ambulatory blood pressure monitoring in relation to Cardiovascular Outcomes (IDACO) investigators. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet 2007;370: 1219-29.
12. Jamieson M, Jamieson C. Ambulatory blood pressure in heart failure. Eur J Clin Invest 2001;31:18-25.
13. Haley RW, Vongpatanasian W, Wolfe GI, Bryan WW, Armitage R, Hoffmann RF, Petty F, Callahan TS, Charuvastra E, Shell WE, Marshall WW, Victor RG. Blunted circadian variation in autonomic regulation of sinus node function in veterans of Gulf war syndrome. Am J Med 2004;117:469-78.
14. Davis SD, Kator SF, Wonnett JA, Pappas BL, Sall JL. Neurally mediated hypotension in fatigued Gulf War veterans: a preliminary report. Am J Med Sci 2000;319:89-95.
15. Mathias CJ, Mallipeddi R, Bleasdale-Barr K. Symptoms associated with orthostatic hypotension in pure autonomic failure and multiple system atrophy. J Neurol 1999;246:893-8.
16. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A, International Chronic Fatigue Syndrome Study Group. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994;121:953-9.
17. Goldblatt J, Taylor PJS, Lipman T, Prince MI, Baragiotta A, Bassendine MF, James OF, Jones DE. The true impact of fatigue in primary biliary cirrhosis: a population study. Gastroenterology 2002;122:1235-41.
18. Newton JL, Allen J, Kerr S, Jones DE. Reduced heart rate variability and baroreflex sensitivity in primary biliary cirrhosis. Liver Int 2006;26: 197-202.
19. Newton JL, Hudson M, Tachtatzis P, Sutcliffe K, Pairman J, Burt JA, Jones DE. The population prevalence of autonomic dysfunction and daytime somnolence in primary biliary cirrhosis. Hepatology 2007;45: 1496-505.
20. Newton JL, Davidson A, Kerr S, Bhala N, Pairman J, Burt J, Jones DE. Autonomic dysfunction in primary biliary cirrhosis correlates with fatigue severity. Eur J Gastroenterol Hepatol 2007;19:125-32.
21. Metcalf JV, Bhopal RS, Gray J, Howel D, James OF. Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England. Int J Epidemiol 1997;26:830-6.
22. O'Brien E, Mee F, Atkins N, O'Malley K. Accuracy of the Spacelabs 90207 determined by the British Hypertension Society protocol. J Hypertension 1991;9:573-4.
23. Staessen JA, Fagard R, Thijs L, Amery A. A consensus view on the technique of ambulatory blood pressure monitoring. The Fourth International Consensus Conference on 24-hour ambulatory blood pressure monitoring. Hypertension 1995;26:912-8.
24. Staessen JA, Bieniaszewski L, O'Brien E, Gosse P, Hayashi H, Imai Y, Kawasaki T, Otsuka K, Palatini P, Thijs L, Fagard R. Nocturnal blood pressure fall on ambulatory monitoring in a large international database. The "Ad Hoc" Working Group. Hypertension 1997;29:30-9.
25. van Ittersum F, Ijzerman RG, Stehouwer CD, Donker AJ. Analysis of twenty-four-hour ambulatory blood pressure monitoring: what time period to assess blood pressures during waking and sleeping? J Hypertension 1995;13:1053-8.
26. Mancia G, Ferrari A, Gregorini L, Parati G, Pomidossi G, Bertinieri G, Grassi G, di Rienzo M, Pedotti A, Zanchetti A. Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circulation Res 1983;53:96-104.
27. Kario K, Matsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada K. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients: advanced silent cerebrovascular damage in extreme dippers. Hypertension 1996;27:130-5.
28. Kario K, Motai K, Mitsuhashi T, Suzuki T, Nakagawa Y, Ikeda U, Matsuo T, Nakayama T, Shimada K. Autonomic nervous system dysfunction in elderly hypertensive patients with abnormal diurnal blood pressure variation: relation to silent cerebrovascular disease. Hypertension 1997;30:1504-10.
29. Keresztes K, Istenes I, Folhoffer A, Lakatos PL, Horvath A, Csak T, Varga P, Kempler P, Szalay F. Autonomic and sensory nerve dysfunction in primary biliary cirrhosis. World J Gastroenterol 2004;10:3030-43.
30. Kikuya M, Hansen TW, Thijs L, Björklund-Bodegård K, Kuznetsova T, Ohkuba T, Richart T, Torp-Pedersen C, Lind L, Ibsen H, Imai Y, Staessen JA, International Database on Ambulatory blood pressure monitoring in relation to Cardiovascular Outcomes Investigators. Diagnostic thresholds for ambulatory blood pressure monitoring based on 10 year cardiovascular risk. Circulation 2007;115:2145-52.
31. Ben-dov IZ, Ben-Arie L, Mekler J, Bursztyn M. Normal ambulatory blood pressure: a clinical practice analysis of recent American Heart Association recommendations. Am J Med 2006;119:13-8.
32. Hansen TW, Kikuya M, Thijs L, Li Y, Boggia J, Björklund- Bodegǎrd K, Torp-Pedersen C, Jeppesen J, Ibsen H, Staessen JA. Diagnostic thresholds for ambulatory blood pressure moving lower: a review based on a meta-analysis-clinical implications. J Clin Hypertension 2008;10: 377-81.
33. Cavelaars M, Tulen JHM, van Bemmel JH, van den Meiracker AH. Physical activity, dipping and haemodynamics. J Hypertension 2004;22: 2303-9.
34. Cavelaars M, Tulen JHM, van Bemmel JH, Mulder PG, van den Meiracker AH. Haemodynamic responses to physical activity and body posture during everyday life. J Hypertension 2004;22:89-96.
35. Cavelaars M, Tulen JHM, van Bemmel JH, ter Borg MJ, Mulder PG, van den Meiracker AH. Determinants of ambulatory blood pressure response to physical activity. J Hypertension 2002;20:2009-15.
36. Pickering TG, Shimbo D, Haas D. Ambulatory blood pressure monitoring. N Engl J Med 2006;355:850-1.
37. Stanton AV. The clinical relevance of extreme dipping. Blood Press Monit 1998;3:163-6.
38. Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension 2001;38:852-7.
39. Swain MG, Le T. Chronic cholestasis in rats induces anhedonia and loss of social interest. Hepatology 1998;28:6-10.
40. Swain MG, Maric M. Improvement in cholestasis-associated fatigue with a serotonin receptor agonist using a novel rat model of fatigue assessment. Hepatology 1997;25:492-4.
41. Van Den Eede F, Moorkens G, Van Houdenhove B, Cosyns P, Claes SJ. Hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome. Neuropsychobiology 2007;55:112-20.
42. McKenzie R, O'Fallon A, Dale J, Demitrack M, Sharma G, Deloria M, Garcia-Borreguero D, Blackwelder W, Straus SE. Low-dose hydrocortisone for the treatment of chronic fatigue syndrome: a randomized controlled trial. JAMA 1998;280:1061-6.
43. Cleare AJ, Heap E, Malhj G, Wessely S, O'Keane V, Miell J. Low dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial. Lancet 1999;353:455-8.
44. Wessely S, Nickson J, Cox B. Symptoms of low blood pressure. BMJ 1990;301:362-5.
45. Rowe PC, Halkins H, Debusk K, McKenzie R, Anand R, Sharma G, Cuccherini BA, Soto N, Hohman P, Snader S, Lucas KE, Wolff M, Straus SE. Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome. JAMA 2001;285:52-9.
46. Peterson PK, Pheley A, Schroeppel J, Schenck C, Marshall P, Kind A, Haugland JM, Lambrecht LJ, Swan S, Goldsmith S. A preliminary placebo controlled crossover trial of fludrocortisone for chronic fatigue syndrome. Arch Intern Med 1998;158:908-14.
47. Naschitz J, Dreyfuss D, Yeshurun D, Rosner I. Midodrine treatment for chronic fatigue syndrome. Postgrad Med J 2004;80:230-2.